Subjective cognitive complaints in cognitively normal adults have been linked to later cognitive decline and dementia. Research on the characteristics of this group has been conducted on a variety of clinical and community-based populations. The current study focuses on the rapidly expanding population of Mexican-American elders.
Objective:
The objective of the study is the determination of characteristics of cognitively normal Mexican-Americans with cognitive complaints.
Methods:
Data on 319 cognitively normal participants in a large-scale community-based study of elderly Mexican-Americans (HABLE) were analyzed comparing those with cognitive complaints with those without on clinical characteristics, affective status, neuropsychological functioning, and proteomic markers.
Results:
Those expressing concern about cognitive decline scored lower on the MMSE, were more likely to have significantly more affective symptoms, higher levels of diabetic markers, poorer performance on attention and executive functioning, and a different pattern of inflammatory markers.
Conclusion:
Although longitudinal research is needed to determine the impact of these differences on later cognition, possible targets for early intervention with Mexican-Americans were identified.
JessenF, WolfsgruberS, WieseB, BickelH, MoschE, KaduszkiewiczH, PentzekM, Riedel-HellerSG, LuckT, FuchsA, WeyererS, WerleJ, Van Den BusscheH, SchererM, MaierW, WagnerM (2014) AD dementia risk in late MCI, in early MCI, and in subjective memory impairment. Alzheimers Dement10, 76–83.
2.
AbnerEL, KryscioRJ, Caban-HoltAM, SchmittFA (2015) Baseline subjective memory complaints associate with increased risk of incident dementia: The PREADVISE trial. J Prev Alzheimers Dis2, 11–16.
3.
KopparaA, WagnerM, LangeC, ErnstA, WieseB, KönigH-H, BrettschneiderC, Riedel-HellerS, LuppaM, WeyererS, WerleJ, BickelH, MöschE, PentzekM, FuchsA, WolfsgruberS, BeauducelA, SchererM, MaierW, JessenF (2015) Cognitive performance before and after the onset of subjective cognitive decline in old age. Alzheimers Dement (Amst)1, 194–205.
KaupAR, NettiksimmonsJ, LeblancES, YaffeK (2015) Memory complaints and risk of cognitive impairment after nearly 2 decades among older women. Neurology85, 1852–1858.
6.
McAlisterC, Schmitter-EdgecombeM (2016) Everyday functioning and cognitive correlates in healthy older adults with subjective cognitive concerns. Clin Neuropsychol30, 1087–1103.
7.
StogmannE, MoserD, KlugS, GleissA, AuffE, Dal-BiancoP, PusswaldG, LehrnerJ (2015) Activities of daily living and depressive symptoms in patients with subjective cognitive decline, mild cognitive impairment, and Alzheimer’s disease. J Alzheimers Dis49, 1043–1050.
8.
BuckleyR, SalingMM, AmesD, RoweCC, LautenschlagerNT, MacaulaySL, MartinsRN, MastersCL, O’MearaT, SavageG, SzoekeC, VillemagneVL, EllisKA (2013) Factors affecting subjective memory complaints in the AIBL aging study: Biomarkers, memory, affect, and age. Int Psychogeriatr25, 1307–1315.
9.
SeoEH, KimH, ChoiKY, LeeKH, ChooIH (2017) Association of subjective memory complaint and depressive symptoms with objective cognitive functions in prodromal Alzheimer’s disease including pre-mild cognitive impairment. J Affect Disord217, 24–28.
10.
HillNL, MogleJ, WionR, MunozE, DePasqualeN, YevchakAM, ParisiJM (2016) Subjective cognitive impairment and affective symptoms: A systematic review. Gerontologist56, 109–127.
11.
ZlatarZZ, MunizM, GalaskoD, SalmonDP (2017) Subjective cognitive decline correlates with depression symptoms and not with concurrent objective cognition in a clinic-based sample of older adults. J Gerontol B Psychol Sci Soc Sci, doi: 10.1093/geronb/gbw207 [Epub ahead of print]
12.
BatesKA, SohrabiHR, RodriguesM, BeilbyJ, DhaliwalSS, TaddeiK, CriddleA, WraithM, HowardM, MartinsG, PatonA, MehtaP, FosterJK, MartinsIJ, LautenschlagerNT, MastagliaFL, LawsSM, GandySE, MartinsRN (2009) Association of cardiovascular factors and Alzheimer’s disease plasma amyloid-beta protein in subjective memory complainers. J Alzheimers Dis17, 305–318.
13.
NguyenLA, HawsKA, FitzhughMC, TorreGA, HishawGA, AlexanderGE (2016) Interactive effects of subjective memory complaints and hypertension on learning and memory performance in the elderly. Aging Neuropsychol Cogn23, 154–170.
14.
ParadiseMB, GlozierNS, NaismithSL, DavenportTA, HickieIB (2011) Subjective memory complaints, vascular risk factors and psychological distress in the middle-aged: A cross-sectional study. BMC Psychiatry11, 108.
15.
ListaS, MolinuevoJL, CavedoE, RamiL, AmouyelP, TeipelSJ, GaraciF, ToschiN, HabertMO, BlennowK, ZetterbergH, O’BryantSE, JohnsonL, GalluzziS, BokdeALW, BroichK, HerholzK, BakardjianH, DuboisB, JessenF, CarrilloMC, AisenPS, HampelH (2015) Evolving evidence for the value of neuroimaging methods and biological markers in subjects categorized with subjective cognitive decline. J Alzheimers Dis48, S171–S191.
O’BryantSE, JohnsonL, BalldinV, EdwardsM, BarberR, WilliamsB, DevousM, CushingsB, KneblJ, HallJ (2013) Characterization of Mexican Americans with mild cognitive impairment and Alzheimer’s disease. J Alzheimers Dis33, 373–379.
19.
EdwardsM, HallJ, WilliamsB, JohnsonL, O’BryantS (2015) Molecular markers of amnestic mild cognitive impairment among Mexican Americans. J Alzheimers Dis49, 221–228.
20.
DownerB, RajiMA, MarkidesKS (2016) Relationship between metabolic and vascular conditions and cognitive decline among older Mexican Americans. Int J Geriatr Psychiatry31, 213–221.
21.
JohnsonLA, GamboaA, VintimillaR, CheatwoodAJ, GrantA, TrivediA, EdwardsM, HallJR, O’BryantSE (2015) Comorbid depression and diabetes as a risk for mild cognitive impairment and Alzheimer’s disease in elderly Mexican Americans. J Alzheimers Dis47, 129–136.
22.
ReinertDF, AllenJP (2002) The Alcohol Use Disorders Identification Test (AUDIT): A review of recent research. Alcohol Clin Exp Res26, 272–279.
23.
JohnsMW (1991) A new method for measuring daytime sleepiness: The Epworth Sleepiness Scale. Sleep14, 540–545.
24.
YesavageJA, BrinkTL, RoseTL, LumO, HuangV, AdeyM, LeirerVO (1983) Development and validation of a geriatric depression screening scale: A preliminary report. J Psychiatr Res17, 37–49.
25.
BeckAT, SteerRA (1990) Manual for the Beck Anxiety Inventory. Behav Res Ther37, 25–74.
26.
MeyerTJ, MillerML, MetzgerRL, BorkovecTD (1990) Development and validation of the Penn State Worry Questionnaire. Behav Res Ther28, 487–495.
27.
FolsteinMF, FolsteinSE, McHughPR (1975) Mini-Mental State: A practice method for grading the cognitive state of patients for the clinician. J Psychiatr Res12, 189–198.
28.
MisdrajiEL, GassCS (2010) The Trail Making Test and its neurobehavioral components. J Clin Exp Neuropsychol32, 159–163.
29.
RoyallDR, MahurinRK, GrayKF (1992) Bedside assessment of executive cognitive impairment - the executive interview. J Am Geriatr Soc40, 1221–1226.
30.
RoyallDR, EspinoDV, PolkMJ, VerdejaR, ValeS, GonzalesH, PalmerRR, MarkidesKP (2003) Validation of a Spanish translation of the CLOX for use in Hispanic samples: The Hispanic EPESE Study. Int J Geriatr Psychiatry18, 135–141.
31.
WhitesideDM, KealeyT, SemlaM, LuuH, RiceL, BassoMR, RoperB (2015) Verbal fluency: Language or executive function measure?Appl Neuropsychol Adult9095, 1–6.
32.
SelnesOA (1991) A compendium of neuropsychological tests: Administration, norms, and commentary. Neurology41, 1856–1856.
33.
WechslerD (1997) Wechsler Memory Scale, third edition. Psychological Corporation.
34.
MorrisJC, HeymanA, MohsRC, HughesJP, van BelleG, FillenbaumG, MellitsED, ClarkC (1989) The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer’s disease. Neurology39, 1159–1165.
35.
LezakMD, HowiesonDB, LoringDW, HannayHJ, FischerJS (2004), Neuropsychological assessment, 4th edition, Oxford University Press, New York.
36.
McKhannG, DrachmanD, FolsteinM, KatzmanR, PriceD, StadlanEM (1984) Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology34, 939–939.
MorrisJC (1993) The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology43, 2412–2412.
39.
O’BryantSE, GuptaV, HenriksenK, EdwardsM, JerominA, ListaS, BazenetC, SoaresH, LovestoneS, HampelH, MontineT, BlennowK, ForoudT, CarrilloM, Graff-RadfordN, LaskeC, BretelerM, ShawL, TrojanowskiJQ, SchupfN, RissmanRA, FaganAM, OberoiP, UmekR, WeinerMW, GrammasP, PosnerH, MartinsR (2015) Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer’s disease research. Alzheimers Dement11, 549–560.
40.
O’BryantSE, XiaoG, BarberR, ReischJ, HallJ, CullumCM, DoodyR, FairchildT, AdamsP, WilhelmsenK, Diaz-ArrastiaR (2011) A blood-based algorithm for the detection of Alzheimer’s disease. Dement Geriatr Cogn Disord32, 55–62.
41.
KuhleJ, RegeniterA, LeppertD, MehlingM, KapposL, LindbergRLP, PetzoldA (2010) A highly sensitive electrochemiluminescence immunoassay for the neurofilament heavy chain protein. J Neuroimmunol220, 114–119.
42.
PusswaldG, MoserD, PflügerM, GleissA, AuffE, StögmannE, Dal-BiancoP, LehrnerJ (2016) The impact of depressive symptoms on health-related quality of life in patients with subjective cognitive decline, mild cognitive impairment, and Alzheimer’s disease. Int Psychogeriatrics28, 2045–2054.
43.
KangS-H, YoonI-Y, LeeSD, KimT, LeeCS, HanJW, KimKW, KimC-H (2017) Subjective memory complaints in an elderly population with poor sleep quality. Aging Ment Health21, 532–536.
44.
Nutter-UphamKE, SaykinAJ, RabinLA, RothRM, WishartHA, PareN, FlashmanLA (2008) Verbal fluency performance in amnestic MCI and older adults with cognitive complaints. Arch Clin Neuropsychol23, 229–241.
45.
HeringaSM, van den BergE, ReijmerYD, NijpelsG, StehouwerCDA, SchalkwijkCG, TeerlinkT, SchefferPG, van den HurkK, KappelleLJ, DekkerJM, BiesselsGJ (2014) Markers of low-grade inflammation and endothelial dysfunction are related to reduced information processing speed and executive functioning in an older population-The Hoorn Study. Psychoneuroendocrinology40, 108–118.
46.
RalphSJ, ClarkI (2015) Supporting evidence for using perispinal etanercept to inhibit TNFα when treating neuropathologies including dementia, chronic stroke, neuropathic pain or traumatic brain injury: Clinical outcomes and role of TNF in neuropathologies other than Alzheimer’s. Healthy Aging Res4, 1–7.
47.
PerrotinA, La JoieR, de La SayetteV, BarréL, MézengeF, MutluJ, GuilloteauD, EgretS, EustacheF, ChételatG (2017) Subjective cognitive decline in cognitively normal eldersfrom the community or from a memory clinic: Differential affectiveand imaging correlates. Alzheimers Dement13, 550–560.
